|27.00||-0.01 / -0.04%|
As of 3:59pm ET
|27.10||+0.10 / +0.37%|
The 5 analysts offering 12-month price forecasts for Aegerion Pharmaceuticals Inc have a median target of 24.00, with a high estimate of 38.00 and a low estimate of 23.00. The median estimate represents a -11.11% decrease from the last price of 27.00.
The current consensus among 6 polled investment analysts is to Hold stock in Aegerion Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.